Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study

Código QR

Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study

Guardado en:

Detalles Bibliográficos
Autores principales:	Lars Lonn, Hein Vincent Stroomberg, Klaus Brasso, Martin Andreas Roder, Petra Svarc, Ruben Juhl Jensen, Susanne Frevert, Mats Håkan Lindh, Mikkel Taudorf
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/06ccd25cc848479dbc95ac5ecc82bc6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016)

High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland.
por: Maria M Wertli, et al.
Publicado: (2021)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida M, et al.
Publicado: (2011)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Michael A. Kiebish, et al.
Publicado: (2021)

Postoperative complications in patients with benign prostatic hyperplasia according to surgical technique
por: Luis Felipe Pérez Medina, et al.
Publicado: (2021)

Postoperative complications in patients with benign prostatic hyperplasia according to surgical technique
por: Luis Felipe Pérez Medina, et al.
Publicado: (2021)

Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?
por: Carolina Bebi, et al.
Publicado: (2021)

Influence of р-thyrozol on the morphology and antioxidant-prooxidant balance in prostate of rats at sulpiride-induced benign prostatic hyperplasia
por: T. G. Borovskaya, et al.
Publicado: (2014)

Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia
por: Zhu D, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Jinze Li, et al.
Publicado: (2021)

High Concentration of Reticular Fibers in Periurethral Region of the Prostatic Urethra from Patients with Benign Prostatic Hyperplasia as Revealed by Stereology
por: Manaia,Jorge H. M, et al.
Publicado: (2012)

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Diaa-Eldin Taha, et al.
Publicado: (2018)

A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia
por: Kristian Leisegang, et al.
Publicado: (2022)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Deli Liu, et al.
Publicado: (2020)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad B, et al.
Publicado: (2019)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee WC, et al.
Publicado: (2013)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak K, et al.
Publicado: (2018)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016)

Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prostatic hyperplasia and coronary artery disease
por: Qingchao Meng, et al.
Publicado: (2021)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
por: Giorgio Ivan Russo, et al.
Publicado: (2021)

Urinary Tract Stones Risk Factors in Patients with Benign Prostatic Hyperplasia in West Java, Indonesia
por: Iman Surendroputro Tjahjodjati, et al.
Publicado: (2021)

Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study.
por: Hasniza Zaman Huri, et al.
Publicado: (2014)

Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
por: Bianka Darvalics
Publicado: (2020)

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Julius Gudmundsson, et al.
Publicado: (2018)

Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
por: McNicholas TA
Publicado: (2016)

Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia
por: Bong Kyun Park, et al.
Publicado: (2019)

The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
por: Yang L, et al.
Publicado: (2021)

Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Tarun Javali, et al.
Publicado: (2018)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Claus G Roehrborn, et al.
Publicado: (2008)

Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia
por: de Sousa VP, et al.
Publicado: (2013)

The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
por: Shaun Wen Huey Lee, et al.
Publicado: (2017)

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
por: Zhu LL, et al.
Publicado: (2015)

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary KT, et al.
Publicado: (2021)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh F, et al.
Publicado: (2020)

Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
por: Magdalena Hagovska, et al.
Publicado: (2021)

Thrombus Embolisation: Prevention is Better than Cure
por: Fizzah A Choudry, et al.
Publicado: (2019)

Increased risk of subsequent benign prostatic hyperplasia in non-Helicobacter pylori-infected peptic ulcer patients: a population-based cohort study
por: Chu-Wen Fang, et al.
Publicado: (2020)

Day care bipolar transurethral resection vs photoselective vaporisation under sedoanalgesia: A prospective, randomised study of the management of benign prostatic hyperplasia
por: Rajeev Sood, et al.
Publicado: (2017)